CVR 45363171Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)AllerødFounded 28 Jan 2025
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about Precision Antibiotics ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
3
CVR, Aug 2026
Gross profit
-702.5K
DKK, annual report 2025
Result
-981K
DKK, annual report 2025
Equity
38.6M
DKK, annual report 2025
TLA-HOLDING 2010 ApSCVR 33359276, 15% to under 20% of capital and votes, since 28 Jan 2025
Bastholm-Hansen Holding ApSCVR 40910689, 15% to under 20% of capital and votes, since 28 Jan 2025
and 2 moreOperating company
Dandex estimate: 3 employees registered in 2026Jonas Rosager Henriksensince 28 Jan 2025
CVR 3335927615% to under 20% of capital and votesnotified 26 Sep 2025since 28 Jan 2025
CVR 4091068915% to under 20% of capital and votesnotified 26 Sep 2025since 28 Jan 2025
CVR 4250423815% to under 20% of capital and votesnotified 26 Sep 2025since 28 Jan 2025
CVR 4586848610% to under 15% of capital and votessince 26 Sep 2025
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
5% to under 10% of capital and votesnotified 26 Sep 202528 Jan 2025 to 26 Sep 2025
CVR 358461665% to under 10% of capital and votesnotified 26 Sep 202528 Jan 2025 to 26 Sep 2025
Decided by Dandex with fixed rules from CVR and the filed annual reports, and for the auditor's report a calibrated decision model reading the auditor's text, not registered by the company. Each label links to its definition.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
28 Jan 2025 to 12 Nov 2026.
Aug 2026, monthly: 3 employees, 3 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| FTE | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Monthly Nov 2025 to Aug 2026.
Latest Aug 2026, published 21 Oct 2026. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2025 |
|---|---|
| Gross profit | -702 |
| Operating profit | -1,102 |
| Result for the year | -981 |
| Equity | 38,629 |
| Total assets | 39,328 |
| Employees (average) | 2 |
| Credit metrics (Dandex calculations) | |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. |
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. |
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. |
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. |
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. |
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group. 2025 covers 11 months (28 Jan to 31 Dec 2025).
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages. Gearing and interest coverage are multiples. Rows marked Pro hold a value in the Pro plan. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
Annual report 2025
28 Jan 2025 to 31 Dec 2025, published 7 Jul 2026
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The rows marked Pro on this page hold values in the Pro plan. For Precision Antibiotics ApS, that is:
Have Pro? Sign in to see the values on this page.
Each registered value from the day it took effect, newest first.
From CVR, read 12 Nov 2026. Text such as the signing rule and purpose is shown as registered.
5 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Bestyrelse:
Fratrådte:
Thomas Lars Andresen, den 30.04.2026, CEO Peter Juul Kristensen, (formand), den 30.04.2026.
Tiltrådte:
Thomas Lars Andresen, (formand), den 30.04.2026.
Vedtægterne er yderligere ændret
Vedtægter ændret: 26.09.2025
Selskabet tegnes af 2 medlemmer af bestyrelsen i forening eller af et bestyrelsesmedlem sammen med en direktør.
Vedtægter ændret: 26.09.2025
Kapitalforhøjelsen er besluttet den 26.09.2025.
kr. 25.600,00, indbetalt kontant, kurs 156.250,00.
Kapitalen udgør herefter kr. 65.600,00.
Bestyrelse:
Tiltrådte:
Thomas Lars Andresen, den 26.09.2025, Anders Elias Hansen, den 26.09.2025, Jonas Rosager Henriksen, den 26.09.2025, Peter Juul Kristensen, (formand), den 26.09.2025, Charlotte Vindfeldt, den 26.09.2025.
Stiftelsesdato: 28.01.2025.
Virkningsdato: 28.01.2025.
Seneste vedtægtsdato: 28.01.2025.
Kapital:
kr. 40.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 40.000,00 til kurs 100,00, fuldt indbetalt.
Stiftere:
Mats Høy Bue, den 28.01.2025, CVR-NR. 33359276 TLA-HOLDING 2010 ApS, c/o Thomas Andresen, Hovmarksvej 73, 2920 Charlottenlund, den 28.01.2025, CVR-NR. 35846166 JUUL KRISTENSEN HOLDING ApS, Adelvej 12A, 8240 Risskov, den 28.01.2025, CVR-NR. 40910689 Bastholm-Hansen Holding ApS, Ådalen 4M, 6710 Esbjerg V, den 28.01.2025, CVR-NR. 42504238 JHSCI Holding ApS, Gravenstensvej 14, 3450 Allerød, den 28.01.2025.
Direktion:
Jonas Rosager Henriksen, den 28.01.2025.
Selskabet tegnes af 1 direktør.
Første regnskabsår:
28.01.2025 - 31.12.2025.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at drive virksomhed med forskning, udvikling og produktion.
1 registered in CVR.
P-number 1031030168Gravenstensvej 14, 3450 Allerød
